Skip to main content
IMS Events Main banner

    Judith S. Hecker, PD Dr. med. (she/her/hers)

    Senior Physician, PI
    TUM University Hospital, Munich Germany

    PD Dr. med. Judith S. Hecker is a senior physician and the head of the Cellular Immunotherapy program, as well as a junior group leader (PI) at TUM University Hospital in Munich, Germany. She is currently conducting a research stay at City of Hope in Los Angeles, CA, USA, within the Van den Brink Lab, focusing on immunotherapeutic approaches, including clinical trials and CAR T-cell engineering.

    With extensive expertise in immunological research and clinical application, Dr. Hecker is dedicated to advancing innovative therapeutic strategies. Her work centers on developing personalized cell therapies and immunological approaches to improve treatment options for cancer and other diseases. Her current research aims to translate cutting-edge developments in CAR T-cell therapy into clinical practice, enhancing efficacy and safety.

    Dr. Hecker combines clinical practice with translational research, bridging laboratory discoveries with patient care. Her leadership in interdisciplinary teams fosters collaboration between basic scientists and clinicians, driving forward novel solutions for complex medical challenges. She is actively involved in the development of next-generation immunotherapies, contributing to clinical trials that seek to optimize these treatments.

    As a recognized expert in her field, Dr. Hecker frequently presents at national and international conferences and publishes her findings in leading scientific journals. Her commitment to medical innovation and patient-centered care positions her as a prominent figure in cellular immunotherapy research.

    Through her work at TranslaTUM, TUM University Hospital, and her current research stay at City of Hope in Los Angeles, CA, she continues to contribute significantly to the advancement of personalized medicine—striving to translate scientific breakthroughs into tangible clinical benefits.

    Disclosure information not submitted.

    Presentation(s):